Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?


Investing as Shakespearean Tragedy: The Story of Ariad Pharmaceutical (ARIA)

By  +Follow November 12, 2013 8:57AM
Tickers Mentioned:

Shares in Ariad Pharmaceuticals (ARIA) were up 10.78 percent on Veterans Day. Even for a small-cap like Ariad, coming in at a valuation just under a half billion dollars, that’s normally what one would consider a pretty solid bounce. That’s a day that, for a lot of investors, would stand out. However, for the battered shareholders of Ariad, it probably doesn’t even register any more. Okay, that’s not true, double-digit jumps always register. But after the Odyssey Ariad’s been on for the last month, it’s not difficult to imagine that days like Monday just get lost in the shuffle.

It’s not often you see a company go on a ride like Ariad just has, plunging sharply, appearing to rally, rinse and repeat. And it’s a drama that’s swept a lot of people up. Over the last 3 months, Ariad’s moved an average of 11.14 million shares a day, good to make it the 75th most traded security over that period, one spot behind Elon Musk’s Tesla Motors (TSLA) , a battleground stock and the source of general market fascination. That’s a class that contains mostly mega-cap blue chips and high-profile ETFS, relatively few small-cap companies. And that’s not even the whole story. Ariad’s heavy volume is drawn mostly from the massive spike this last month. Over the last 30 days Aria has been moving an average of 20 million shares a day, meaning that more than 10 percent of outstanding shares are trading hands on an average day.

So what’s happening with this company? The story’s a simple one, but, for Ariad investors, it’s a tragic one.

Volatile Month

Lets start with the whole story: since the start of October, Ariad Pharmaceutical’s stock has lost over 85 percent of its value. No matter how specifically you pull things apart, that’s the simple fact one cannot avoid. Especially if you’ve owned Ariad for that whole stretch. But inside that one big sell-off is a series of daily price moves that could drive an investor insane. Here’s a timeline or the events that have brought Ariad so much grief:

October 8:

After market close, news gets out regarding the clinical trials for Ariad’s leukemia drug Iclusig and it’s bad. In fact, if you’re long Ariad, it’s positively awful. The drug showed blood clots developing in 11.8 percent of people treated with Iclusig after 24 months. This was a big jump from the 8 percent rate found after 11 months, and it prompts the FDA to block Ariad from enrolling any new patients to drug trials for Iclusig.

Like most small-cap pharma companies, Ariad’s future is tied mainly to just a couple of drugs, and the news that one of them might not be safe is pretty drastic. Especially when one considers that the nearly 800 percent gains from the start of 2010 to October 7 had a lot to do with the fact that Iclusig looked so promising, even getting accelerated approval based on its Phase 2 clinical data.

So it shouldn’t be surprising that the market’s reaction was swift and vengeful. As soon as investors got a crack at selling their position on October 9 shares plummeted over 65 percent.

October 10-18:

If the story ended there, it would be pretty much in line with a familiar narrative: small-cap pharma plummets on negative results of clinical trial. But, while nothing matched the degree of the move on the ninth, Ariad kept trading at heavy volumes and kept posting double-digit moves.

A series of analyst downgrades hit the company on October 10, with Barclays (BCS) downgrading the stock from overweight to underweight and cutting the price target from $25 a share to $4 (ouch). The stock kept falling, losing another 30 percent from October 10-16 but coasting into what appeared to be a bottom on October 16.

Then, on October 17, signs of life! Following comments from JP Morgan (JPM) analyst Cory Kasimov that physicians may not be all that concerned about the blood clots, the stock rebounded, posting a 10.78 percent gain and potentially giving hope to Ariad owners that the worst was behind them.

Except that it wasn’t. Not at all. October 18, word came out that Ariad and the FDA had agreed to halt testing of Iclusig entirely based on the rate of blood clotting incidences. The discontinuation of the late-stage trial dubbed Epic by Ariad caused shares to plunge more than 40 percent that day.

October 21-October 30:

After any stock gets hammered that hard in that short a period, one might expect it to bounce back. At least a little. Considering how steep the discount it’s trading at as compared to a mere two weeks ago, it has to garner at least a little interest, right?

And it did. The company staged a pretty substantial rally, gaining almost 50 percent in just nine days. It’s not much when one considers just how fall the stock fell prior to the rally, but at least the battered shareholders got a respite in the end, right?

October 31:

Only it wasn’t the end. Halloween was extra spooky if you had decided to wait out Ariad’s steep decline. Ariad announced that it would suspend marketing and distribution of Iclusig while it "continues to negotiate updates to the U.S. prescribing information." In retrospect, it certainly seems as though this shouldn’t have been all that surprised, but it clearly surprised at least some people as the company’s stock plunged nearly 45 percent.

And Beyond…?

Where Ariad’s going from here is unclear. Since the start of November, the stock’s up over 15 percent, including a 17.27 percent leap the day after Halloween and Monday’s double-digit gain. However, precisely what to expect moving forward is unclear. In the event that Ariad can return Iclusig to the market and ensure that it’s safe, there’s a pretty good chance the stock takes off. That said, there’s no real way to know whether or not that’s possible. In the meantime, the company announced that it was shedding 40 percent of its American-based workforce on November 7.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.

Signup for our daily newsletter and get our best articles emailed right to you!

Results for ARIA
19 Sep 14 11:51:23
Highest Put/Call ratios today $SIRI $IGT $ARIA $BTU http://t.co/rq3MExgoa0
19 Sep 14 10:59:14
$ARIA: Iclusig TRx/NRx are 61/29, -57/ -36% wk/wk respectively, in week 34 since the January re-launch. OVERSTATED http://t.co/Jjig0B7rHJ
Investors Hangout
19 Sep 14 10:18:37
jim50: $ARIA Open Date=Sept-19-2014 Open=5.82 High=6.02 http://t.co/5DHUW1wuJZ
Investors Hangout
19 Sep 14 10:18:37
jim50: $ARIA Open Date=Sept-19-2014 Open=5.82 High=6.02 http://t.co/JM1FV42q82
Victor Roberts, MD
19 Sep 14 10:14:05
Commented on StockTwits: good article from AF supporting Denner, activist investor in $ARIA ! WS loves these kind... http://t.co/U8muosvs6S
19 Sep 14 10:10:50
$ARIA Open Date=Sept-19-2014 Open=5.82 High=6.02 Low=5.79 Close=5.96 Volume=3283129 http://t.co/LVZwlGSDbB
19 Sep 14 10:06:57
$ARIA getting ready to rally! #iPhone6 $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
Michael Torres, PhD
19 Sep 14 10:02:28
RT @WrigleyTom: Some #Biotech #Healthcare #MedicalDevices working (11am) $AMGN $CELG $KERX $VRTX $JNJ $XON $ATHN $COO $WCG $ARIA $NVO $SHP…
19 Sep 14 09:52:08
$SH Chart $SH Most recent stock chart and technical analysis. $AA $SOHU $V $SUNE $CPRX $ARIA http://stockchart http://t.co/bahmyryHQo
19 Sep 14 09:46:45
is that a new symbol for $ARIA? $ARNA
19 Sep 14 09:34:26
RT @InvestorsLive: $ARIA hello $6
19 Sep 14 09:11:27
RT @adamfeuerstein: $ARIA Director Resignation May Mean CEO Berger One Step Closer to Exit http://t.co/6VtoXA7qNN via @TheStreet
Kenneth Meyerson
19 Sep 14 09:10:05
Can we do $10m in money flow? $ARIA
Adam Feuerstein
19 Sep 14 09:08:13
$ARIA Director Resignation May Mean CEO Berger One Step Closer to Exit http://t.co/6VtoXA7qNN via @TheStreet
19 Sep 14 08:52:55
MidCap #Stocks Performance $CNQR $DRC $COL $GLNG $AEO $NOW $NI $N $ATI $RAX $FEYE $WEN $AWAY $ARIA $DSW more@ http://t.co/tf79gD96D3
19 Sep 14 08:41:41
$PFE Parabolic SAR $PFE Most recent stock chart and technical analysis. $LGF $ARIA $X $LUV $VTI $MYEC http://s http://t.co/cFT9GSPdg4
19 Sep 14 08:33:28
$MTVX Chart $MTVX Most recent stock chart and technical analysis. $ARIA $GOOGL $GMZ $BBRY $MTVX $QIHU http://s http://t.co/JOmEZQEujj
19 Sep 14 08:10:55
Highest Put/Call ratios today $SIRI $IGT $ARIA $BTU http://t.co/nroS3iwfEV
Christian Kat
19 Sep 14 08:04:57
$ARIA interesting setup
19 Sep 14 08:01:29
$ARIA - takeover target by $SHPG? Stock was near $25/share! #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland
Tom Wrigley
19 Sep 14 08:01:20
Some #Biotech #Healthcare #MedicalDevices working (11am) $AMGN $CELG $KERX $VRTX $JNJ $XON $ATHN $COO $WCG $ARIA $NVO $SHPG $AEGR nHod's
19 Sep 14 07:59:43
$ARIA - takeover target by $SHPG?! http://t.co/o1SxKUpaUq $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland
19 Sep 14 07:58:50
$ARIA has that crazy look in its eye...
19 Sep 14 07:57:05
$ARIA - takeover target? http://t.co/o1SxKUpaUq #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
Ezra Valdez
19 Sep 14 07:55:17
RT @InvestorsLive: $ARIA hello $6
19 Sep 14 07:55:15
$ARIA - takeover target?! http://t.co/o1SxKUpaUq #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
Investors Hangout
19 Sep 14 07:54:34
danrocks: $HYG Making Some Noise $UVXY $C $ARIA $JNJ $TBT http://t.co/gAsWK3lG0b
Investors Hangout
19 Sep 14 07:54:16
danrocks: $HYG Making Some Noise $UVXY $C $ARIA $JNJ $TBT http://t.co/gOCDKYN9gI
Nathan Michaud
19 Sep 14 07:54:07
$ARIA hello $6
19 Sep 14 07:54:07
$ARIA - $6! #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
Alexander Morris
19 Sep 14 07:53:39
$ARIA: At 1DyHIGH=5.98, hits:1, ch:+3.8%, 0phNewHi, tf:1f, MedFlt[157.0M], HiPctSht[26%:5d], DyVol:2.65M:0.6x:0.3x, DyRng:3.2%:0.6x:0.8x
19 Sep 14 07:52:20
$ACI $ARIA $JRJC $PLUG autocharts @ http://t.co/hj7PGeTQk3
19 Sep 14 07:50:00
$HYG Making Some Noise $UVXY $C $ARIA $JNJ $TBT http://t.co/nd0xUkgoaV
Investors Hangout
19 Sep 14 07:49:38
Emylers: $ARIA Up to date company activities and other http://t.co/OY3jOHJMTi
Investors Hangout
19 Sep 14 07:49:37
Emylers: $ARIA Up to date company activities and other http://t.co/7SDqmKf77Q
19 Sep 14 07:34:22
$ACHN $ARIA $ARNA $JMEI $RWLK autocharts @ http://t.co/hj7PGeTQk3
19 Sep 14 07:33:13
$ARIA - will #Shire buyout #Ariad???? #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
19 Sep 14 07:31:24
$ARIA rallying - buyout news coming?? #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
19 Sep 14 07:29:05
$ARIA - here comes key $6 level and HUGE SQUEEZE #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
19 Sep 14 07:27:52
BLOCK TRADE: $ARIA 295,700 shares @ $5.90 [10:27:52]
19 Sep 14 07:23:26
$ARIA Up to date company activities and other important information about $ARIA http://t.co/XdCYjYnjev
19 Sep 14 07:19:43
$UNH TA $UNH Most recent stock chart and technical analysis. $TLT $INTC $ARIA $SCTY $FXI $XLY http://stockchar http://t.co/UYILkk4upo
19 Sep 14 07:19:23
$ARIA - rallying on HUGE volume!!! #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
19 Sep 14 07:09:29
$LVS Las Vegas Sands (LVS) 63.74 -0.21 (-0.33%) $IBM $VVUS $ARIA http://t.co/rI7IxFysQc
19 Sep 14 07:00:20
TNA Stock Chart $TNA $ARIA $XLK $UNG http://t.co/1UV0vXUv2T http://t.co/2neWKSnmmb
19 Sep 14 06:44:51
$ARIA - rallying on HUGE volume! Buyout???? #news $BABA $pfe $jnj $dndn $ctic $kerx $GSK #Ebola $aapl $REGN #scottland #JanetYellen
T Abuhasna
19 Sep 14 06:10:21
$ARIA $S $VPOR $PSID... Let's PRESS these today as everyone buying and dumping BABA on the highs
Thomas Collins
19 Sep 14 05:30:49
$ARIA Ariad shrinks size of footprint in Kendall Sq. http://t.co/lXXbbhY6Uq
19 Sep 14 05:30:49
$ARIA Why Ariad Pharmaceuticals, Inc. Stock Plunged 11% in 2014 http://t.co/omLORc94di
George Avidon
19 Sep 14 05:30:10
RT @TheTradeXchange: Top Insider Purchases - $POL CEO 10000 $35.27 $ARIA CEO 25000 $6.27 $AIRT CEO 3050 $12.89 $MILL EC 100000 $5.03 $ULT…
By  +Follow November 12, 2013 8:57AM



blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.